Trials / Conditions / Refractory Diffuse Intrinsic Pontine Glioma
Refractory Diffuse Intrinsic Pontine Glioma
4 registered clinical trials studyying Refractory Diffuse Intrinsic Pontine Glioma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors NCT05278208 | Nationwide Children's Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors NCT03598244 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors NCT03387020 | Pediatric Brain Tumor Consortium | Phase 1 |
| Active Not Recruiting | Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diff NCT02359565 | National Cancer Institute (NCI) | Phase 1 |